Altimmune to Present at Upcoming Conferences
March 08 2021 - 4:01PM
Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical
company, today announced that members of the management team will
present during a fireside chat at the H.C. Wainwright Global Life
Sciences Conference, being held Mar 9-10, 2021. Also, Altimmune’s
Chief Medical Officer, Dr. Scott Harris, will be giving an oral
presentation at the 2021 NASH-TAG Conference, being held March
11-13, 2021.
Details on the H.C. Wainwright fireside chat
presentation are as follows:
Title: |
H.C.
Wainwright Global Life Sciences Conference |
Presenters: |
Vipin Garg, Ph.D., Chief Executive OfficerScot Roberts, Ph.D.,
Chief Scientific OfficerScott Harris, M.D., Chief Medical
Officer |
Date/Time: |
March 9, 2021 at 7:00 am ET |
A webcast link to the H.C. Wainwright fireside
chat presentation will be accessible on the Events section of the
Altimmune website.
Details on the NASH-TAG 2021 presentation by Dr.
Scott Harris are as follows:
Title: |
Dual GLP-1
Agonists in the Treatment of Metabolic& Liver Dysfunction in
NASH |
Presenter: |
Scott Harris M.D., Chief Medical Officer |
Date/Time: |
March 13, 2021 at 9:30 pm ET |
A copy of the presentation materials will be
accessible on the Events section of the Altimmune website.
About Altimmune
Altimmune is a clinical stage biopharmaceutical
company focused on developing intranasal vaccines, immune
modulating therapies and treatments for liver disease. Our diverse
pipeline includes proprietary intranasal vaccines for COVID-19
(AdCOVID™), anthrax (NasoShield™) and influenza (NasoVAX™); an
intranasal immune modulating therapeutic for COVID-19 (T-COVID™);
and next generation peptide therapeutics for NASH (ALT-801) and
chronic hepatitis B (HepTcell™). For more information on Altimmune,
please visit www.altimmune.com.
Investor & Media Contacts:
Will
Brown |
Stacey
Jurchison |
Chief Financial Officer |
Sr. Dir, Investor Relations |
Phone: 240-654-1450 |
Phone : 410-474-8200 |
wbrown@altimmune.com |
sjurchison@altimmune.com |
Altimmune (NASDAQ:ALT)
Historical Stock Chart
From Aug 2024 to Sep 2024
Altimmune (NASDAQ:ALT)
Historical Stock Chart
From Sep 2023 to Sep 2024